Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEP for HIV Prevention in Japanese MSM Toward Tokyo Olympics
jRCTs031180134Completed
- Sponsor
- Ministry of Health, Labour and Welfare
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Ministry of Health, Labour and Welfare. Primary endpoint: Incidence of HIV infection among MSM on PrEP (/100 person-year). Started Apr 2018; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on jRCTs031180134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180134.